Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Sodium Chloride × 90 days × Clear all

Sponsor

Conditions

Brain Neoplasms 3 Pancreatic Neoplasms 2 Lung Neoplasms 2 Warts 1 Surgical Wound 1 Squamous Cell Carcinoma of Head and Neck 1 Sigmoid Neoplasms 1 Rectal Neoplasms 1 Neuroinflammatory Diseases 1 Melanoma 1 Lung Injury 1 Locally Advanced Cervical Cancer 1 Limited Stage Small Cell Lung Cancer 1 Hypoxia 1 Hemorrhage 1 Hematologic Neoplasms 1 HIV Infections 1 Gliosarcoma 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Colorectal Neoplasms 1 Breast Neoplasms 1

Interventions

fludarabine 3 fludarabine phosphate 2 Whole-Body Irradiation 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Cyclophosphamide 2 Busulfan 2 trametinib 1 repotrectinib 1 pralsetinib 1 ponatinib 1 pembrolizumab 1 gilteritinib 1 durvalumab 1 dabrafenib 1 Pemetrexed 1 Paclitaxel 1 Immunotherapy 1 Idarubicin 1 Granulocyte Colony-Stimulating Factor 1 Gemcitabine 1 Cytarabine 1 Cisplatin 1 Carboplatin 1 Bone Marrow Transplantation 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡